99% Purity Powder Female Hormone Mifepristone for Anti-Pregnancy CAS 84371-65-3

Model NO.: Mifepristone cas 84371-65-3
Product Name: Female Progesterone Hormone Powder Mifepristone
Alias: Mifepristone
CAS No: 84371-65-3
Mf: C29h35no2
Grade: Pharmaceutical Grade
Standard: Enterprise Standard
Uses: Body Building
Business Type: Manufacturer Factory
Storage: Shading, Confined Preservation
Product Categories: Steroids;Hormone;Acetylenes;Biochemistry
Trademark: YIHAN
Transport Package: Foil Bag or Tin
Specification: 800kg/M
Origin: China
HS Code: 3001200010
Model NO.: Mifepristone cas 84371-65-3
Product Name: Female Progesterone Hormone Powder Mifepristone
Alias: Mifepristone
CAS No: 84371-65-3
Mf: C29h35no2
Grade: Pharmaceutical Grade
Standard: Enterprise Standard
Uses: Body Building
Business Type: Manufacturer Factory
Storage: Shading, Confined Preservation
Product Categories: Steroids;Hormone;Acetylenes;Biochemistry
Trademark: YIHAN
Transport Package: Foil Bag or Tin
Specification: 800kg/M
Origin: China
HS Code: 3001200010
 
 Female Hormone Mifepristone for Anti-Pregnancy CAS 84371-65-3

Mifepristone Basic Info:
CAS No.: 84371-65-3
Molecular Formula: C29H35NO2
Molecular Weight: 429.65
Purity: 99%min
Appearance: White or almost white or pale yellow crystalline powder
Density: 1.18 g/cm3
Boiling Point: 628.6 ° C at 760 mmHg
Refractive Index: 1.623
Grade: Pharmaceutical Grade
Storage: Shading, confined preservation

Mifepristone/Mifeprex Powder Description:
"Mifepristone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.
 
A progestational and glucocorticoid hormone antagonist. Its inhibition of progesterone induces bleeding during the luteal phase and in early pregnancy by releasing endogenous prostaglandins from the endometrium or decidua. As a glucocorticoid receptor antagonist, the drug has been used to treat hypercortisolism in patients with nonpituitary CUSHING SYNDROME.
 
The use of mifepristone as an anti-implantation agent in the primate has been explored in the rhesus monkey with two specific aims: (i) to determine the contraceptive efficacy of very low-dose mifepristone administered on mated cycle days 16, 17, and 18; and (ii) to test the hypothesis that alteration in endometrial prostaglandin milieu by using either prostaglandin analogue or prostaglandin synthesis inhibitor can intervene the antifertility effect induced by mifepristone.
 
How To Use Mifepristone/Mifeprex Powder :
1.Mifepristone comes with an extra patient information sheet called a Medication Guide and a Patient Agreement. Read them carefully. Read them again each time you get mifepristone refilled.
2.Mifepristone is supplied by your health care provider and is not available at a pharmacy.
3.Mifepristone requires 3 visits to your health care provider.
 
4.On day 1 at your health care provider's office, you will read the Medication Guide and discuss the benefits and risks of using mifepristone to end your pregnancy. If you decide mifepristone is right for you, sign the Patient Agreement. After your physical exam, you will take 3 tablets of mifepristone.
 
5.On day 3 at your health care provider's office, if you are still pregnant, you will take 2 misoprostol tablets. Misoprostol may cause cramps, nausea, diarrhea, and other symptoms. Your health care provider may give you other medicines for these symptoms.

CERTIFICATE OF ANALYSIS

Product name

Mifepristone
CAS No.
84371-65-3
Outer Packing
1KG/drum
Production date
2014.11.04
Shelf life
2017.11.03
Standard adopted CP 2010/Enterprise standard
Items of analysis Specification Results
Description Light Yellowish Crystalline Powder Light Yellowish Crystalline Powder
Identification the maximum absorption wavelength of 304nm, 260nm, and infrared absorption spectra were consistent with the control product. Conformity
Melting Point 192ºC~196ºC

192ºC~196ºC
192ºC~196ºC

192ºC~196ºC
Specific Rotation +124°~ +129°

+124°~ +129°
+127.3°

+127.3°
Single Impurity ≤0.5%

≤0.5%
0.45%

0.45%


Total Impurity

≤1.0%

≤1.0%

0.60%

0.60%
Loss On Drying ≤0.5%

≤0.5%
0.2%

0.2%
Assay ≥98.5%

≥98.5%
99.4%

99.4%
Sieve analysis ≤30μm

≤30μm
Conformity

Conclusion

Qualified

99% Purity Powder Female Hormone Mifepristone for Anti-Pregnancy CAS 84371-65-3

 
99% Purity Powder Female Hormone Mifepristone for Anti-Pregnancy CAS 84371-65-3

99% Purity Powder Female Hormone Mifepristone for Anti-Pregnancy CAS 84371-65-3
99% Purity Powder Female Hormone Mifepristone for Anti-Pregnancy CAS 84371-65-3

 
 
 Female Hormone Mifepristone for Anti-Pregnancy CAS 84371-65-3

Mifepristone Basic Info:
CAS No.: 84371-65-3
Molecular Formula: C29H35NO2
Molecular Weight: 429.65
Purity: 99%min
Appearance: White or almost white or pale yellow crystalline powder
Density: 1.18 g/cm3
Boiling Point: 628.6 ° C at 760 mmHg
Refractive Index: 1.623
Grade: Pharmaceutical Grade
Storage: Shading, confined preservation

Mifepristone/Mifeprex Powder Description:
"Mifepristone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.
 
A progestational and glucocorticoid hormone antagonist. Its inhibition of progesterone induces bleeding during the luteal phase and in early pregnancy by releasing endogenous prostaglandins from the endometrium or decidua. As a glucocorticoid receptor antagonist, the drug has been used to treat hypercortisolism in patients with nonpituitary CUSHING SYNDROME.
 
The use of mifepristone as an anti-implantation agent in the primate has been explored in the rhesus monkey with two specific aims: (i) to determine the contraceptive efficacy of very low-dose mifepristone administered on mated cycle days 16, 17, and 18; and (ii) to test the hypothesis that alteration in endometrial prostaglandin milieu by using either prostaglandin analogue or prostaglandin synthesis inhibitor can intervene the antifertility effect induced by mifepristone.
 
How To Use Mifepristone/Mifeprex Powder :
1.Mifepristone comes with an extra patient information sheet called a Medication Guide and a Patient Agreement. Read them carefully. Read them again each time you get mifepristone refilled.
2.Mifepristone is supplied by your health care provider and is not available at a pharmacy.
3.Mifepristone requires 3 visits to your health care provider.
 
4.On day 1 at your health care provider's office, you will read the Medication Guide and discuss the benefits and risks of using mifepristone to end your pregnancy. If you decide mifepristone is right for you, sign the Patient Agreement. After your physical exam, you will take 3 tablets of mifepristone.
 
5.On day 3 at your health care provider's office, if you are still pregnant, you will take 2 misoprostol tablets. Misoprostol may cause cramps, nausea, diarrhea, and other symptoms. Your health care provider may give you other medicines for these symptoms.

CERTIFICATE OF ANALYSIS

Product name

Mifepristone
CAS No.
84371-65-3
Outer Packing
1KG/drum
Production date
2014.11.04
Shelf life
2017.11.03
Standard adopted CP 2010/Enterprise standard
Items of analysis Specification Results
Description Light Yellowish Crystalline Powder Light Yellowish Crystalline Powder
Identification the maximum absorption wavelength of 304nm, 260nm, and infrared absorption spectra were consistent with the control product. Conformity
Melting Point 192ºC~196ºC

192ºC~196ºC
192ºC~196ºC

192ºC~196ºC
Specific Rotation +124°~ +129°

+124°~ +129°
+127.3°

+127.3°
Single Impurity ≤0.5%

≤0.5%
0.45%

0.45%


Total Impurity

≤1.0%

≤1.0%

0.60%

0.60%
Loss On Drying ≤0.5%

≤0.5%
0.2%

0.2%
Assay ≥98.5%

≥98.5%
99.4%

99.4%
Sieve analysis ≤30μm

≤30μm
Conformity

Conclusion

Qualified

99% Purity Powder Female Hormone Mifepristone for Anti-Pregnancy CAS 84371-65-3

 
99% Purity Powder Female Hormone Mifepristone for Anti-Pregnancy CAS 84371-65-3

99% Purity Powder Female Hormone Mifepristone for Anti-Pregnancy CAS 84371-65-3
99% Purity Powder Female Hormone Mifepristone for Anti-Pregnancy CAS 84371-65-3

Â